1. Home
  2. DVA vs ALGN Comparison

DVA vs ALGN Comparison

Compare DVA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DaVita Inc.

DVA

DaVita Inc.

N/A

Current Price

$180.74

Market Cap

14.9B

Sector

Health Care

ML Signal

N/A

Logo Align Technology Inc.

ALGN

Align Technology Inc.

N/A

Current Price

$180.19

Market Cap

12.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DVA
ALGN
Founded
1994
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9B
12.7B
IPO Year
2003
2000

Fundamental Metrics

Financial Performance
Metric
DVA
ALGN
Price
$180.74
$180.19
Analyst Decision
Hold
Buy
Analyst Count
4
12
Target Price
$156.75
$199.82
AVG Volume (30 Days)
958.3K
860.9K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.53
EPS
6.86
3.09
Revenue
$13,643,069,000.00
$387,126,000.00
Revenue This Year
$3.85
$5.78
Revenue Next Year
$3.07
$4.62
P/E Ratio
$26.11
$57.02
Revenue Growth
6.46
23.95
52 Week Low
$101.00
$122.00
52 Week High
$247.49
$200.44

Technical Indicators

Market Signals
Indicator
DVA
ALGN
Relative Strength Index (RSI) 27.40 57.68
Support Level $176.59 $164.70
Resistance Level $202.63 $186.82
Average True Range (ATR) 8.14 6.46
MACD -5.52 0.76
Stochastic Oscillator 6.65 69.87

Price Performance

Historical Comparison
DVA
ALGN

About DVA DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: